Comparison of the incidence of contrast-induced nephropathy after primary PCI in patients receiving high-dose rosuvastatin and atorvastatin

INTRODUCTION: Contrast-induced nephropathy (CIN) is associated with increased disability and death. Randomized clinical trial studies have shown that short-term treatment with statins prior to cardiac intervention was capable of reducing the incidence of CIN. Therefore, the aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Golshani, Samad, Tavasoli, Parastoo, Farsavian, Ali Asghar, Farsavian, Hossein, Charati, Jamshid Yazdani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254854/
https://www.ncbi.nlm.nih.gov/pubmed/35800554
http://dx.doi.org/10.4103/jfmpc.jfmpc_1344_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254854/
https://www.ncbi.nlm.nih.gov/pubmed/35800554
http://dx.doi.org/10.4103/jfmpc.jfmpc_1344_21

Ejemplares similares